159 related articles for article (PubMed ID: 29937983)
1. Selective Irreversible Inhibitors of the Wnt-Deacylating Enzyme NOTUM Developed by Activity-Based Protein Profiling.
Suciu RM; Cognetta AB; Potter ZE; Cravatt BF
ACS Med Chem Lett; 2018 Jun; 9(6):563-568. PubMed ID: 29937983
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective fatty acylation is essential for the release of lipidated WNT proteins from the acyltransferase Porcupine (PORCN).
Tuladhar R; Yarravarapu N; Ma Y; Zhang C; Herbert J; Kim J; Chen C; Lum L
J Biol Chem; 2019 Apr; 294(16):6273-6282. PubMed ID: 30737280
[TBL] [Abstract][Full Text] [Related]
3. An
Asciolla JJ; Miele MM; Hendrickson RC; Resh MD
J Biol Chem; 2017 Aug; 292(33):13507-13513. PubMed ID: 28655768
[TBL] [Abstract][Full Text] [Related]
4. Functional regulation of Wnt protein through post-translational modifications.
Yu J; Virshup DM
Biochem Soc Trans; 2022 Dec; 50(6):1797-1808. PubMed ID: 36484635
[TBL] [Abstract][Full Text] [Related]
5. Identification of key residues and regions important for porcupine-mediated Wnt acylation.
Rios-Esteves J; Haugen B; Resh MD
J Biol Chem; 2014 Jun; 289(24):17009-19. PubMed ID: 24798332
[TBL] [Abstract][Full Text] [Related]
6. Modulating Wnt signaling at the root: Porcupine and Wnt acylation.
Torres VI; Godoy JA; Inestrosa NC
Pharmacol Ther; 2019 Jun; 198():34-45. PubMed ID: 30790642
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms and inhibition of Porcupine-mediated Wnt acylation.
Liu Y; Qi X; Donnelly L; Elghobashi-Meinhardt N; Long T; Zhou RW; Sun Y; Wang B; Li X
Nature; 2022 Jul; 607(7920):816-822. PubMed ID: 35831507
[TBL] [Abstract][Full Text] [Related]
8. Selective N-Hydroxyhydantoin Carbamate Inhibitors of Mammalian Serine Hydrolases.
Cognetta AB; Niphakis MJ; Lee HC; Martini ML; Hulce JJ; Cravatt BF
Chem Biol; 2015 Jul; 22(7):928-37. PubMed ID: 26120000
[TBL] [Abstract][Full Text] [Related]
9.
Lee CJ; Rana MS; Bae C; Li Y; Banerjee A
J Biol Chem; 2019 Jan; 294(1):231-245. PubMed ID: 30420431
[TBL] [Abstract][Full Text] [Related]
10. Extracellular carriers control lipid-dependent secretion, delivery, and activity of WNT morphogens.
de Almeida Magalhaes T; Liu J; Chan C; Borges KS; Zhang J; Kane AJ; Wierbowski BM; Ge Y; Liu Z; Mannam P; Zeve D; Weiss R; Breault DT; Huang P; Salic A
Dev Cell; 2024 Jan; 59(2):244-261.e6. PubMed ID: 38154460
[TBL] [Abstract][Full Text] [Related]
11. The logistics of Wnt production and delivery.
Alvarez-Rodrigo I; Willnow D; Vincent JP
Curr Top Dev Biol; 2023; 153():1-60. PubMed ID: 36967191
[TBL] [Abstract][Full Text] [Related]
12. Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling.
Bayle ED; Svensson F; Atkinson BN; Steadman D; Willis NJ; Woodward HL; Whiting P; Vincent JP; Fish PV
J Med Chem; 2021 Apr; 64(8):4289-4311. PubMed ID: 33783220
[TBL] [Abstract][Full Text] [Related]
13. Small-molecule inhibitors of carboxylesterase Notum.
Zhao Y; Jolly S; Benvegnu S; Jones EY; Fish PV
Future Med Chem; 2021 Jun; 13(11):1001-1015. PubMed ID: 33882714
[TBL] [Abstract][Full Text] [Related]
14. NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition.
Madan B; Ke Z; Lei ZD; Oliver FA; Oshima M; Lee MA; Rozen S; Virshup DM
Oncotarget; 2016 Mar; 7(11):12386-92. PubMed ID: 26848981
[TBL] [Abstract][Full Text] [Related]
15. Design of a Potent, Selective, and Brain-Penetrant Inhibitor of Wnt-Deactivating Enzyme Notum by Optimization of a Crystallographic Fragment Hit.
Willis NJ; Mahy W; Sipthorp J; Zhao Y; Woodward HL; Atkinson BN; Bayle ED; Svensson F; Frew S; Jeganathan F; Monaghan A; Benvegnù S; Jolly S; Vecchia L; Ruza RR; Kjær S; Howell S; Snijders AP; Bictash M; Salinas PC; Vincent JP; Jones EY; Whiting P; Fish PV
J Med Chem; 2022 May; 65(10):7212-7230. PubMed ID: 35536179
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Optimization of a Porcupine Inhibitor.
Duraiswamy AJ; Lee MA; Madan B; Ang SH; Tan ES; Cheong WW; Ke Z; Pendharkar V; Ding LJ; Chew YS; Manoharan V; Sangthongpitag K; Alam J; Poulsen A; Ho SY; Virshup DM; Keller TH
J Med Chem; 2015 Aug; 58(15):5889-99. PubMed ID: 26110200
[TBL] [Abstract][Full Text] [Related]
17. Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface.
Traister A; Shi W; Filmus J
Biochem J; 2008 Mar; 410(3):503-11. PubMed ID: 17967162
[TBL] [Abstract][Full Text] [Related]
18. Notum deacylates Wnt proteins to suppress signalling activity.
Kakugawa S; Langton PF; Zebisch M; Howell S; Chang TH; Liu Y; Feizi T; Bineva G; O'Reilly N; Snijders AP; Jones EY; Vincent JP
Nature; 2015 Mar; 519(7542):187-192. PubMed ID: 25731175
[TBL] [Abstract][Full Text] [Related]
19. Fatty acylation of Wnt proteins.
Nile AH; Hannoush RN
Nat Chem Biol; 2016 Feb; 12(2):60-9. PubMed ID: 26784846
[TBL] [Abstract][Full Text] [Related]
20. Discovery of 2-phenoxyacetamides as inhibitors of the Wnt-depalmitoleating enzyme NOTUM from an X-ray fragment screen.
Atkinson BN; Steadman D; Zhao Y; Sipthorp J; Vecchia L; Ruza RR; Jeganathan F; Lines G; Frew S; Monaghan A; Kjær S; Bictash M; Jones EY; Fish PV
Medchemcomm; 2019 Aug; 10(8):1361-1369. PubMed ID: 31534655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
